How Asia-Pacific Adalimumab Market is Expanding Amid Growing Biologic Therapy Demand
"Global Executive Summary Asia-Pacific Adalimumab Market: Size, Share, and Forecast
CAGR Value
The expected CAGR of adalimumab market is tend to be around 7.10 % in the mentioned forecast period. The market was valued at USD 920.18 million in 2022, and it would grow upto USD 1592.9 million by 2030.
Keeping into consideration the customer requirement, this Asia-Pacific Adalimumab...
0 hisse senetleri
95 Views